Cencora Buys American Oncology Network in $2.4B Deal, Lifts FY26 EPS View
COR sits 40% above its 52-week low of $244.82.
Summary
Cencora signed a definitive agreement to acquire American Oncology Network, valuing AON at $2.4B enterprise value — $2.3B at closing plus up to $100M in contingent value rights. Cencora already owns about 4% of AON and expects to pay roughly $1.7B in cash to reach 75% ownership, assuming certain stockholders roll over up to 25% of the equity. AON brings 350-plus oncology providers across 21 states into Cencora's physician-led MSO network, extending its community oncology footprint. Management expects the deal to be accretive to adjusted diluted EPS in year two post-closing, and separately nudged FY2026 adjusted EPS guidance to at least $17.90, the high end of the prior $17.75-$17.95 range. Closing hinges on regulatory clearances and AON stockholder approval; AON's board approved on a special committee recommendation. Cencora will lay out FY2027 expectations on its November 4, 2026 earnings call.
At the time of this announcement, COR was trading at $342.51 on NYSE in the Trade & Services sector, with a market capitalization of approximately $65.5B. The 52-week trading range was $244.82 to $377.54. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: BusinessWire.